On ECHEMI
Home > Drugs > Henan Lixin Pharmaceutical Limited By Share Ltd
Henan Lixin Pharmaceutical Limited By Share Ltd
  • Founded in:

    2002-01-16
  • Country:

    China China
  • Address:

    Nanyang Zhenping Industrial Park
  • Tax NO.:

    91411300733847073D
  • Registered Funds:

    124.58389 million yuan
  • Website:

  • Email:

Related Drugs
Ranitidine Hydrochloride Injection
The main ingredient of this product is: Ranitidine hydrochloride. Its chemical name is: Nprime;-methyl-N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]-methyl]thio]ethyl]-2-nitro-1,1-ethylenediamine hydrochloride. Structural formula: (see Ranitidine hydrochloride capsules) Molecular formula: C13H22N4O3SHCl Molecular weight: 350.87
Name Description Content CAS NO. Registered Holders
Ranitidine Hydrochloride

H2 receptor antagonist, significantly inhibits the basal and nocturnal gastric acid secretion in normal people and ulcer patients, as well as the gastric acid secretion caused by pentagastrin, histamine and meals; has a certain inhibitory effect on the secretion of pepsinogen; has a protective effect on experimental gastric mucosal damage and acute ulcers; has no effect on the secretion of gastrin and sex hormones.

More

H2 receptor antagonist, significantly inhibits the basal and nocturnal gastric acid secretion in normal people and ulcer patients, as well as the gastric acid secretion caused by pentagastrin, histamine and meals; has a certain inhibitory effect on the secretion of pepsinogen; has a protective effect on experimental gastric mucosal damage and acute ulcers; has no effect on the secretion of gastrin and sex hormones.

66357-59-3 49
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.